DeCell Technologies Inc. is a Biomedical Technology innovation company that is developing advanced tissue products for use in wound healing and surgical reconstructions. DeCell Technologies’ main facilities are located in Nova Scotia, Canada.
Our patented, innovative prECM™ technology processes donated human tissue removing cellular components (source of rejection) while leaving the structural protein matrix of the tissue intact. During processing, potential bacteria and viruses are also deactivated and removed resulting in a sterile, safe, and effective biological scaffold that promotes tissue regeneration when implanted into a patient. Unique automated manufacturing equipment developed in-house ensures quality and consistency of our product at a low cost.